• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丁酰胆碱酯酶基因的K变体与病理确诊的阿尔茨海默病之间无关联。

No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease.

作者信息

Singleton A B, Smith G, Gibson A M, Woodward R, Perry R H, Ince P G, Edwardson J A, Morris C M

机构信息

MRC Neurochemical Pathology Unit, Institute for the Health of the Elderly, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne, NE4 6BE UK.

出版信息

Hum Mol Genet. 1998 May;7(5):937-9. doi: 10.1093/hmg/7.5.937.

DOI:10.1093/hmg/7.5.937
PMID:9536100
Abstract

The polymorphic K variant of the butyrylcholinesterase ( BCHE-K ) gene recently has been demonstrated to have an elevated frequency in Alzheimer's disease (AD) patients carrying the epsilon4 allele of the apolipoprotein (APO E) gene when compared with a control population. We therefore genotyped a large series of pathologically confirmed AD patients and controls to confirm this association. We found no change in the frequency of this genetic variant, either in the AD group as a whole or in early- or late-onset patients when compared with age-matched controls. Stratification of these groups with reference to the APO E epsilon4 allele also showed no difference between AD and control groups. To determine if a biological effect were present, we also looked at senile plaque and neurofibrillary tangle densities in the frontal, temporal, parietal and occipital cortices in AD patients either carrying or not carrying a copy of the K variant. We found no difference in plaque or tangle load between these two groups in either the total, late-onset or early-onset AD subjects. Stratification of the total AD group in terms of APO E epsilon4 allele possession, and further comparison of plaque and tangle load between carriers and non-carriers of BCHE-K still failed to disclose a relationship between BCHE-K and AD. We conclude that in the population studied here there is no association between BCHE-K and AD, or that if such a relationship exists it is precluded by another, as yet unknown factor.

摘要

与对照人群相比,近期研究表明,携带载脂蛋白(APO E)基因ε4等位基因的阿尔茨海默病(AD)患者中,丁酰胆碱酯酶(BCHE-K)基因的多态性K变体频率升高。因此,我们对大量经病理证实的AD患者和对照进行基因分型,以确认这种关联。我们发现,与年龄匹配的对照相比,无论是在整个AD组,还是在早发或晚发患者中,这种基因变体的频率均无变化。根据APO Eε4等位基因对这些组进行分层分析,AD组与对照组之间也没有差异。为了确定是否存在生物学效应,我们还观察了携带或未携带K变体拷贝的AD患者额叶、颞叶、顶叶和枕叶皮质中的老年斑和神经原纤维缠结密度。我们发现,在总AD患者、晚发或早发AD患者中,这两组之间的斑块或缠结负荷均无差异。根据是否拥有APO Eε4等位基因对总AD组进行分层,并进一步比较BCHE-K携带者和非携带者之间的斑块和缠结负荷,仍未发现BCHE-K与AD之间存在关联。我们得出结论,在本研究人群中,BCHE-K与AD之间不存在关联,或者说,如果存在这种关系,也会被另一个未知因素所排除。

相似文献

1
No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease.丁酰胆碱酯酶基因的K变体与病理确诊的阿尔茨海默病之间无关联。
Hum Mol Genet. 1998 May;7(5):937-9. doi: 10.1093/hmg/7.5.937.
2
No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.丁酰胆碱酯酶K变体基因与载脂蛋白E4在晚发性阿尔茨海默病中无关联。
Am J Med Genet. 1999 Apr 16;88(2):113-5. doi: 10.1002/(sici)1096-8628(19990416)88:2<113::aid-ajmg2>3.0.co;2-3.
3
Failure to confirm a synergistic effect between the K-variant of the butyrylcholinesterase gene and the epsilon4 allele of the apolipoprotein gene in Japanese patients with Alzheimer's disease.在日本阿尔茨海默病患者中未能证实丁酰胆碱酯酶基因的K-变体与载脂蛋白基因的ε4等位基因之间存在协同效应。
J Neurol Neurosurg Psychiatry. 1999 Jul;67(1):94-6. doi: 10.1136/jnnp.67.1.94.
4
Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease.在确诊的阿尔茨海默病中,APOE ε4与丁酰胆碱酯酶-K之间存在协同关联的进一步证据。
Hum Genet. 1999 Feb;104(2):158-63. doi: 10.1007/s004390050929.
5
Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.认知健康老龄化与阿尔茨海默病的临床病理研究:组织学标志物与痴呆严重程度、年龄、性别及载脂蛋白E基因型的关系。
Arch Neurol. 1998 Mar;55(3):326-35. doi: 10.1001/archneur.55.3.326.
6
Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.二肽基羧肽酶1(DCP1)和丁酰胆碱酯酶(BCHE)基因与载脂蛋白Eε4等位基因的相互作用,作为阿尔茨海默病以及伴有阿尔茨海默病理共存的帕金森病的风险因素。
J Med Genet. 2000 Oct;37(10):766-70. doi: 10.1136/jmg.37.10.766.
7
Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease.丁酰胆碱酯酶K变体基因与载脂蛋白E4在晚发型确诊阿尔茨海默病中的协同作用。
Hum Mol Genet. 1997 Oct;6(11):1933-6. doi: 10.1093/hmg/6.11.1933.
8
Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients.丁酰胆碱酯酶K变体和载脂蛋白E4基因在芬兰晚发性阿尔茨海默病患者中不存在协同作用。
Neurosci Lett. 1998 Jun 26;250(1):69-71. doi: 10.1016/s0304-3940(98)00453-4.
9
Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland.丁酰胆碱酯酶K变体在基因上与北爱尔兰晚发性阿尔茨海默病相关。
J Med Genet. 2000 Mar;37(3):182-5. doi: 10.1136/jmg.37.3.182.
10
Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.组织蛋白酶D外显子2 C→T多态性与阿尔茨海默病之间的遗传关联以及与基因型的病理相关性。
J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):515-7. doi: 10.1136/jnnp.2005.063917.

引用本文的文献

1
Confirmed Synergy Between the ɛ4 Allele of Apolipoprotein E and the Variant K of Butyrylcholinesterase as a Risk Factor for Alzheimer's Disease: A Systematic Review and Meta-Analysis.载脂蛋白E的ɛ4等位基因与丁酰胆碱酯酶变体K之间的协同作用被确认为阿尔茨海默病的一个风险因素:一项系统评价和荟萃分析。
J Alzheimers Dis Rep. 2023 Jun 19;7(1):613-625. doi: 10.3233/ADR-220084. eCollection 2023.
2
Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer's Disease-Could Genotyping Be Helpful in Alzheimer's Therapy?丁酰胆碱酯酶蛋白在阿尔茨海默病发病机制中的作用——基因分型在阿尔茨海默病治疗中有用吗?
Biomolecules. 2019 Oct 9;9(10):592. doi: 10.3390/biom9100592.
3
Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.
丁酰胆碱酯酶 K 变异体 N 端区域的改变与载脂蛋白 E4 在晚发性阿尔茨海默病中的协同作用。
Sci Rep. 2019 Mar 26;9(1):5223. doi: 10.1038/s41598-019-41578-3.
4
Association between butyrylcholinesterase K variant and mild cognitive impairment in the Thai community-dwelling patients.泰国社区居住患者中丁酰胆碱酯酶K变异体与轻度认知障碍之间的关联。
Clin Interv Aging. 2017 May 26;12:897-901. doi: 10.2147/CIA.S137264. eCollection 2017.
5
Association of and with Alzheimer's disease: Meta-analysis based on 56 genetic case-control studies of 12,563 cases and 12,622 controls.[基因名称1]和[基因名称2]与阿尔茨海默病的关联:基于对12563例病例和12622例对照的56项基因病例对照研究的荟萃分析。
Exp Ther Med. 2015 May;9(5):1831-1840. doi: 10.3892/etm.2015.2327. Epub 2015 Mar 3.
6
Butyrylcholinesterase K variant and Alzheimer's disease risk: a meta-analysis.丁酰胆碱酯酶K变异体与阿尔茨海默病风险:一项荟萃分析。
Med Sci Monit. 2015 May 16;21:1408-13. doi: 10.12659/MSM.892982.
7
A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease.丁酰胆碱酯酶作为阿尔茨海默病治疗靶点的综述。
Prim Care Companion CNS Disord. 2013;15(2). doi: 10.4088/PCC.12r01412. Epub 2013 Mar 7.
8
It all starts at the ends: multifaceted involvement of C- and N-terminally modified cholinesterases in Alzheimer's disease.一切都始于末端:C 端和 N 端修饰的胆碱酯酶在阿尔茨海默病中的多方面参与。
Rambam Maimonides Med J. 2010 Oct 31;1(2):e0014. doi: 10.5041/RMMJ.10014. Print 2010 Oct.
9
BuChE K variant is decreased in Alzheimer's disease not in fronto-temporal dementia.BuChE K 变异体在阿尔茨海默病中减少,而不在额颞叶痴呆中减少。
J Neural Transm (Vienna). 2010 Mar;117(3):377-83. doi: 10.1007/s00702-009-0358-y.
10
Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.二肽基羧肽酶1(DCP1)和丁酰胆碱酯酶(BCHE)基因与载脂蛋白Eε4等位基因的相互作用,作为阿尔茨海默病以及伴有阿尔茨海默病理共存的帕金森病的风险因素。
J Med Genet. 2000 Oct;37(10):766-70. doi: 10.1136/jmg.37.10.766.